As filed with the Securities and Exchange Commission on March 30, 2021
Registration No. 333-
UNITED STATES
SECURITIES AND EXCHANGE COMMISSION
Washington, D.C. 20549
FORM S-8
REGISTRATION STATEMENT
UNDER
THE SECURITIES ACT OF 1933
QUOTIENT LIMITED
(Exact name of registrant as specified in its charter)
| | |
Jersey, Channel Islands | | Not applicable |
(State or other jurisdiction of incorporation or organization) | | (I.R.S. Employer Identification No.) |
| |
B1, Business Park Terre Bonne, Route de Crassier 13, 1262 Eysins, Switzerland 011-41-22-716-9800 | | Not applicable |
(Address of Principal Executive Offices) | | (ZIP Code) |
Inducement Share Option Award
Inducement Restricted Share Unit Award
Inducement Performance-Based Restricted Share Unit Award
(Full Title of the Plan)
Jeremy Stackawitz
Quotient Biodiagnostics, Inc.
301 South State Street, Suite S-204
Newtown, Pennsylvania 18940
(215) 497-8820
(Name, address and telephone number, including area code, of agent for service)
Copies to:
Kathleen Werner, Esq.
Clifford Chance US LLP
31 West 52nd Street
New York, NY 10019
(212) 878-8000
Indicate by check mark whether the registrant is a large accelerated filer, an accelerated filer, a non-accelerated filer, or a smaller reporting company. See the definitions of “large accelerated filer,” “accelerated filer” and “smaller reporting company” in Rule 12b-2 of the Exchange Act.
| | | | | | |
Large accelerated filer | | ☐ | | Accelerated filer | | ☐ |
| | | |
Non-accelerated filer | | ☒ | | Smaller reporting company | | ☒ |
| | | |
| | | | Emerging growth company | | ☐ |
If an emerging growth company, indicate by check mark if the registrant has elected not to use the extended transition period for complying with any new or revised financial accounting standards provided pursuant to Section 7(a)(2)(B) of the Securities Act. ☐
CALCULATION OF REGISTRATION FEE
| | | | | | | | |
|
Title of Securities to be Registered | | Amount to be Registered(1) | | Proposed Maximum Offering Price Per Share | | Proposed Maximum Aggregate Offering Price | | Amount of Registration Fee |
Ordinary shares of no par value | | | | | | | | |
— Inducement Share Option Award to Manuel Mendez | | 831,590 shares(2) | | $3.72(3) | | $3,093,514(3) | | $337.50 |
— Inducement Restricted Share Unit Award to Manuel Mendez | | 1,035,088 shares(2) | | $3.72(3) | | $3,850,527(3) | | $420.10 |
— Inducement Performance-Based Restricted Share Unit Award to Manuel Mendez | | 263,158 shares(2) | | $3.72(3) | | $978,948(3) | | $106.80 |
TOTAL | | 2,129,836 shares | | — | | $7,922,989 | | $864.40 |
|
|
(1) | Pursuant to Rule 416(a) under the Securities Act of 1933, as amended (the “Securities Act”), this registration statement shall also cover any additional ordinary shares of no par value (“Ordinary Shares”), that become issuable in respect of the securities identified in the above table by reason of any share dividend, share split, recapitalization or similar transaction effected without the receipt of consideration that increases the number of outstanding Ordinary Shares. |
(2) | The number of Ordinary Shares underlying options to purchase Ordinary Shares or issuable upon the vesting and settlement of restricted share unit awards (performance and non-performance) granted to Mr. Mendez has been estimated for the purpose of calculating the registration fee and has been determined based in part upon recent trading activity of the Ordinary Shares of Quotient Limited (the “Registrant”) reported on the Nasdaq Global Market. The actual number of such Ordinary Shares will be determined on the actual grant date of the awards. The Ordinary Shares referenced in this footnote (2) will be granted as an inducement material to his acceptance of employment with the Registrant, in accordance with the inducement grant exception under Nasdaq Rule 5635(c)(4). |
(3) | Estimated solely for the purpose of calculating the amount of the registration fee pursuant to Rule 457(c) and Rule 457(h) promulgated under the Securities Act based upon the average of the high and low sales prices of the Ordinary Shares reported on The Nasdaq Global Market on March 25, 2021. |